Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

Updates in the Treatment and Management of Bladder Cancer

Integrity CE

M. Galsky, B. Guercio

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

Review of Bladder Cancer Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

GnRH Agonists vs. Antagonists in Prostate Cancer

Patrick Campbell